THC Pharm GmbH has been producing and distributing Dronabinol, the analgesic and antispasmodic pure active ingredient of the cannabis plant, since 1998. Despite rapid growth over the last years the substance is classified as a prescribable narcotic, we have been holding on to our roots as a patient-based initiative and have been looking for new ways of developing herbal-based effective substances and base agents.

Maripharm was established in 1995 for the purpose of developing medicines from cannabis. At patients’ request, Maripharm supplied Medical Grade Cannabis (MGC) through pharmacists (1995-2003). Maripharm is the only ISO-certificated company in the Netherlands that is engaged in cannabis and cannabinoids.

GW Pharmaceuticals is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of non-smoked prescription medicines derived from cannabis, including SativexR, to meet patient needs in a wide range of therapeutic indications. The Group has also expanded its research to include the use of other controlled drugs in conjunction with its proprietary secure drug dispensing technology.

To use evidence in educating clinicians and current medical cannabis users of the benefits and risks of cannabis as a medicine while researching and developing novel pharmaceutical products that target the endocannabinoid system.

The Office of Medicinal Cannabis is the organisation of the Dutch Governement which is responsible for the production of cannabis for medical and scientifical purposes. The Office delivers medicinal cannabis of high quality. The office has the monopoly of the trade in cannabis. Due to an international treaty the Netherlands are obliged to organize its Office this way. The OMC has also the monopoly on the import and export of cannabis and cannabisresin and the OMC decideds about the exemptions of posession of cannabis and cannabisresin.

SIMM (Stichting Institute of Medical Marijuana) was launched in The Netherlands in 1993. SIMM offers the highest quality of organically-grown medical cannabis on the market today. Since 1993, we have provided superior cannabis to patients, physicians, pharmacists and researchers. Our purpose...To produce and supply patients with high quality medical cannabis, at the lowest possible price; organically grown in soil in a clean environment, and properly handled throughout the growing/curing process

Echo Pharmaceuticals develops and produces novel cannabinoids-based pharmaceutical products via our patented processes, which are indicated for the treatment of numerous diseases and for applications such as pain treatment, nausea and vomiting, anorexia and spasticity.

This comprehensive web site provides information on the multiple　benefits of MARINOL.
The Endocannabinoid System Animation

In December 2000, based on the success and security of the underground facility, Health Canada awarded PPS a 5-year, $5.5 million contract for The Development of Comprehensive Operations Environmental divisionfor the Cultivation and Fabrication of Medicinal Marihuana. This project operates in the biosecure underground growth chamber in Flin Flon, Manitoba.

Cannabis Science works with World Authorities on phytocannabinoid science targeting critical illnesses. Adhering to scientific methodologies to develop, produce, and commercialize phytocannabinoid based